Female infertility. Female infertility of uterine origin, Nonimplantation of ovum
Conditions
Interventions
5 mg oral Medroxyprogesterone acetate twice a day for twenty days from 16th day of menstruation.
Treatment - Drugs
5 mg oral Medroxyprogesterone acetate twice a day for twenty days from 16th day of menstruation
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: women aged 20-40? willingness to participate in the study? lack of pregnancy in inclusion time? endometrial thickness less than 8 milimeter by trans vaginal ultrasound? minimum 1 year unexplained infertility history or more than 3 times of repeated failure of implantation ? normal semen analysis according to WHO criteria. Exclusion criteria: willingness to use assisted reproductive technology? use of hormones in 1 month ago? debilitating disease of the ovary such as polycystic ovarian syndrome.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: Before intervention and after intervention. Method of measurement: Transvaginal ultrasound.;Pregnancy rate. Timepoint: After interventin. Method of measurement: Gravindex test and transvaginal ultrasound.;Relationship between endometrial thickness and pregnancy rate. Timepoint: Before and after intervention. Method of measurement: Gravindex test and transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Behnaz Sadeghzadeh Oskuei
Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences
Outcome results
None listed